Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Aisner

Showing results (221-230 of 235) with videos related to

Pageof 24
Sort By:
Cancer Treatment Reports|June 1, 1984
Multiple sequential biomarkers in monitoring patients with carcinoma of the lungR S Aroney, W C Dermody, P Aldenderfer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Dose-response trial of megestrol acetate in advanced breast cancer: cancer and leukemia group B phase III study 8741J Abrams, J Aisner, C Cirrincione, et al.
The New England Journal of Medicine|August 12, 1999
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative GroupA Aupérin, R Arriagada, J P Pignon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group BA B Kornblith, D R Hollis, E Zuckerman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234N J Vogelzang, J E Herndon, A Miller, et al.
American Journal of Clinical Oncology|June 1, 1984
A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5-drug chemotherapy for advanced breast cancer. A Cancer and Leukemia Group B studyD C Tormey, V E Weinberg, L A Leone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1987
Chemohormonal therapy in advanced carcinoma of the breast: Cancer and Leukemia Group B protocol 8081M C Perry, C G Kardinal, A H Korzun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Phase I trial, including pharmacokinetic and pharmacodynamic correlations, of combination paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancerC P Belani, C M Kearns, E G Zuhowski, et al.
Medicine|January 1, 1982
Carcinomatous leptomeningitis in small cell lung cancer: a clinicopathologic review of the National Cancer Institute experienceS T Rosen, J Aisner, R W Makuch, et al.
Cancer|October 12, 2001
Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinomaR S DiPaola, E S Chenven, W J Shih, et al.
Pageof 24

Showing results (221-230 of 235) with videos related to

Sort By:
Pageof 24
Cancer Treatment Reports|June 1, 1984
Multiple sequential biomarkers in monitoring patients with carcinoma of the lungR S Aroney, W C Dermody, P Aldenderfer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Dose-response trial of megestrol acetate in advanced breast cancer: cancer and leukemia group B phase III study 8741J Abrams, J Aisner, C Cirrincione, et al.
The New England Journal of Medicine|August 12, 1999
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative GroupA Aupérin, R Arriagada, J P Pignon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group BA B Kornblith, D R Hollis, E Zuckerman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234N J Vogelzang, J E Herndon, A Miller, et al.
American Journal of Clinical Oncology|June 1, 1984
A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5-drug chemotherapy for advanced breast cancer. A Cancer and Leukemia Group B studyD C Tormey, V E Weinberg, L A Leone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1987
Chemohormonal therapy in advanced carcinoma of the breast: Cancer and Leukemia Group B protocol 8081M C Perry, C G Kardinal, A H Korzun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Phase I trial, including pharmacokinetic and pharmacodynamic correlations, of combination paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancerC P Belani, C M Kearns, E G Zuhowski, et al.
Medicine|January 1, 1982
Carcinomatous leptomeningitis in small cell lung cancer: a clinicopathologic review of the National Cancer Institute experienceS T Rosen, J Aisner, R W Makuch, et al.
Cancer|October 12, 2001
Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinomaR S DiPaola, E S Chenven, W J Shih, et al.
Pageof 24